We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Novel Digital Morphology Analyzer Performance Evaluated

By LabMedica International staff writers
Posted on 01 Dec 2022
Print article
Image: The CellaVision DC-1 is a stand-alone hematology analyzer that performs blood cell differentials. It offers a suitable solution for laboratories with small workloads (Photo courtesy of Sysmex)
Image: The CellaVision DC-1 is a stand-alone hematology analyzer that performs blood cell differentials. It offers a suitable solution for laboratories with small workloads (Photo courtesy of Sysmex)

Microscopic examination of peripheral blood smear (PBS) is essential in clinical hematology laboratories. Manual counting is, however, inefficient because the process is technically demanding and labor-intensive resulting in long turnaround time (TAT), and the results may be subjective with inter-observer variation.

Digital morphology (DM) analyzers can provide analysis of cell morphology (pre-classification) with reduced TAT and inter-observer variation. In a recent study, DM analyzers showed advantages over manual counting in laboratory efficiency including shortened TAT. DM analyzers can be used mainly in large-volume laboratories, and they are too large and expensive to be used in small to medium-volume laboratories.

Medical Laboratory Scientists at the Konkuk University School of Medicine (Seoul, Korea) obtained PBS slides from healthy individuals, spanning normal white blood cell (WBC) range including mild leukopenia (2.0–4.0 × 109/L) and mild leukocytosis (10.0–15.0 × 109/L). WBC counts in these samples were 3.90 × 109/L, 5.19 × 109/L, 6.72 × 109/L, 8.72 × 109/L, and 10.78 × 109/L, respectively. Venous whole blood samples were collected and were used for complete blood counts in XN-9000 (Sysmex, Kobe, Japan), and PBS slides were made and reviewed for WBC differentials.

The Sysmex CellaVision DC-1 (DC1) is a newly launched digital morphology analyzer that was developed mainly for small to medium-volume laboratories. The scientists evaluated the precision, qualitative performance, comparison of cell counts between DC-1 and manual counting, and turnaround time (TAT) of DC-1. Pre-classification on DC-1 included total 18 cell classes (12 WBC classes and six non-WBC classes). The 12 WBC classes include blasts, promyelocytes, myelocytes, metamyelocytes, band neutrophils, segmented neutrophils, lymphocytes, monocytes, eosinophils, basophils, variant lymphocytes, and plasma cells. The six non-WBC classes include nucleated RBCs (nRBCs), smudge cells, artifact, giant platelet, platelet aggregation, and unidentified cells.

The investigators reported that DC-1 showed excellent precision (%CV, 0.0%–3.5%), high specificity (98.9%–100.0%), and high negative predictive value (98.4%–100.0%) in 18 cell classes (12 WBC classes and six non-WBC classes). However, DC-1 showed 0% of positive predictive value in seven cell classes (metamyelocytes, myelocytes, promyelocytes, blasts, plasma cells, nucleated red blood cells, and unidentified). The largest absolute mean differences (%) of DC-1 versus manual counting was 2.74. Total TAT (min:s) was comparable between DC-1 (8:55) and manual counting (8:55).

The authors concluded that their study showed that DC-1 has a reliable analytical performance in all cell classes, and it can be used in small-to medium-volume laboratories for providing assist of manpower in daily practice of PBS review. However, DC-1 may make unnecessary workload for cell verification in some cell classes. The study was published on October 31, 2022 in the journal Clinical Chemistry and Laboratory Medicine.

Related Links:
Konkuk University School of Medicine
Sysmex

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.